Biocept Inc. (BIOCQ)

Biocept Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2022	2021	2020	2019	2018
Market Capitalization	0	9	61	59	7	3
Market Cap Growth	-95.49%	-85.17%	2.50%	803.53%	88.46%	-83.36%
Enterprise Value	5	8	45	57	-0	2
PE Ratio	-	-0.28	-21.59	-3.34	-0.26	-0.14
PS Ratio	0.00	0.35	1.00	2.17	1.19	1.08
PB Ratio	0.00	1.02	1.63	2.51	0.59	1.15
P/FCF Ratio	-0.04	-0.64	28.79	-2.88	-0.28	-0.16
P/OCF Ratio	-0.04	-0.68	16.52	-3.01	-0.29	-0.16
EV/Sales Ratio	3.66	0.32	0.73	2.09	-0.03	0.52
EV/EBITDA Ratio	-0.20	-0.28	196.39	-3.46	0.01	-0.07
EV/EBIT Ratio	-0.19	-0.26	-18.59	-3.26	0.01	-0.07
EV/FCF Ratio	-0.31	-0.59	21.14	-2.78	0.01	-0.08
Debt / Equity Ratio	39.97	1.37	0.34	0.52	0.23	0.53
Debt / EBITDA Ratio	-0.41	-0.41	55.58	-0.74	-0.11	-0.07
Debt / FCF Ratio	-0.64	-0.86	5.98	-0.59	-0.11	-0.07
Quick Ratio	1.52	2.73	3.62	2.28	2.31	1.08
Current Ratio	1.81	2.97	3.88	2.61	2.50	1.30
Asset Turnover	0.05	0.54	1.10	0.77	0.30	0.28
Interest Coverage	-156.61	-100.94	-8.31	-74.45	-99.56	-78.01
Return on Equity (ROE)	-411.90%	-133.00%	-8.50%	-75.90%	-219.60%	-438.10%
Return on Assets (ROA)	-104.00%	-66.60%	-5.10%	-49.80%	-136.40%	-217.60%
Return on Capital (ROIC)	-279.08%	-152.53%	-4.80%	-43.06%	-167.80%	-519.56%
Earnings Yield	-11682442.75%	-354.90%	-4.63%	-29.94%	-383.70%	-721.62%
FCF Yield	-6947328.24%	-155.91%	3.47%	-34.72%	-361.29%	-644.12%
Buyback Yield / Dilution	-83.94%	-14.74%	-24.74%	-473.32%	-638.38%	-205.30%
Total Shareholder Return	-83.94%	-14.74%	-24.74%	-473.32%	-638.38%	-205.30%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).